| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
|
Circulation
|
2006
|
13.21
|
|
2
|
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
|
J Am Coll Cardiol
|
2006
|
5.70
|
|
3
|
One-year cardiovascular event rates in outpatients with atherothrombosis.
|
JAMA
|
2007
|
5.61
|
|
4
|
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.
|
JAMA
|
2006
|
5.00
|
|
5
|
Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study.
|
Circulation
|
2011
|
4.95
|
|
6
|
Critical issues in peripheral arterial disease detection and management: a call to action.
|
Arch Intern Med
|
2003
|
4.72
|
|
7
|
ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)--summary of recommendations.
|
J Vasc Interv Radiol
|
2006
|
3.59
|
|
8
|
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2011
|
2.71
|
|
9
|
Exercise training for claudication.
|
N Engl J Med
|
2002
|
2.26
|
|
10
|
Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events.
|
Stroke
|
2004
|
2.24
|
|
11
|
Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.
|
Am Heart J
|
2008
|
2.09
|
|
12
|
Treatment of peripheral arterial disease--extending "intervention" to "therapeutic choice".
|
N Engl J Med
|
2006
|
1.98
|
|
13
|
Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
|
JAMA
|
2010
|
1.97
|
|
14
|
Correlates of delayed recognition and treatment of acute type A aortic dissection: the International Registry of Acute Aortic Dissection (IRAD).
|
Circulation
|
2011
|
1.97
|
|
15
|
Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry.
|
Eur Heart J
|
2009
|
1.84
|
|
16
|
Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial.
|
J Am Coll Cardiol
|
2010
|
1.59
|
|
17
|
Utility and barriers to performance of the ankle-brachial index in primary care practice.
|
Vasc Med
|
2004
|
1.57
|
|
18
|
Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial.
|
J Am Coll Cardiol
|
2003
|
1.54
|
|
19
|
Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study.
|
J Am Soc Nephrol
|
2007
|
1.53
|
|
20
|
A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life.
|
J Am Coll Cardiol
|
2008
|
1.50
|
|
21
|
Descending aortic diameter of 5.5 cm or greater is not an accurate predictor of acute type B aortic dissection.
|
J Thorac Cardiovasc Surg
|
2011
|
1.49
|
|
22
|
The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design.
|
Am Heart J
|
2006
|
1.45
|
|
23
|
Claudication: exercise vs endoluminal revascularization (CLEVER) study update.
|
J Vasc Surg
|
2009
|
1.43
|
|
24
|
Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
1.39
|
|
25
|
The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program.
|
Vasc Med
|
2008
|
1.37
|
|
26
|
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2013
|
1.36
|
|
27
|
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus.
|
Am J Cardiol
|
2002
|
1.30
|
|
28
|
Peripheral arterial disease: lack of awareness in Canada.
|
Can J Cardiol
|
2009
|
1.23
|
|
29
|
The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods.
|
J Vasc Surg
|
2008
|
1.22
|
|
30
|
Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.
|
Atherosclerosis
|
2005
|
1.21
|
|
31
|
One-year costs in patients with a history of or at risk for atherothrombosis in the United States.
|
Circ Cardiovasc Qual Outcomes
|
2008
|
1.21
|
|
32
|
A call to action: women and peripheral artery disease: a scientific statement from the American Heart Association.
|
Circulation
|
2012
|
1.19
|
|
33
|
Atherosclerotic risk factor reduction in peripheral arterial diseasea: results of a national physician survey.
|
J Gen Intern Med
|
2002
|
1.19
|
|
34
|
2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline).
|
Vasc Med
|
2011
|
1.19
|
|
35
|
Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study.
|
Am J Public Health
|
2009
|
1.18
|
|
36
|
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
|
Atherosclerosis
|
2008
|
1.16
|
|
37
|
Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry).
|
Am J Cardiol
|
2010
|
1.13
|
|
38
|
2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery.
|
J Vasc Surg
|
2011
|
1.13
|
|
39
|
Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
|
Crit Pathw Cardiol
|
2009
|
1.11
|
|
40
|
Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.
|
J Am Coll Cardiol
|
2012
|
1.09
|
|
41
|
The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008.
|
Prev Chronic Dis
|
2011
|
1.07
|
|
42
|
A patient-derived perspective of health-related quality of life with peripheral arterial disease.
|
J Nurs Scholarsh
|
2002
|
1.06
|
|
43
|
Clinical significance of a high ankle-brachial index: insights from the Atherosclerosis Risk in Communities (ARIC) Study.
|
Atherosclerosis
|
2006
|
1.04
|
|
44
|
Multidisciplinary standardized care for acute aortic dissection: design and initial outcomes of a regional care model.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
1.03
|
|
45
|
Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry.
|
Eur Heart J
|
2008
|
1.02
|
|
46
|
An international model to predict recurrent cardiovascular disease.
|
Am J Med
|
2012
|
1.02
|
|
47
|
Peripheral artery disease and CKD: a focus on peripheral artery disease as a critical component of CKD care.
|
Am J Kidney Dis
|
2012
|
1.02
|
|
48
|
Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) study.
|
Vasc Med
|
2009
|
1.01
|
|
49
|
Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
|
J Vasc Surg
|
2008
|
1.01
|
|
50
|
Peripheral arterial disease rehabilitation: a review.
|
J Cardiopulm Rehabil
|
2003
|
0.97
|
|
51
|
Atherosclerotic Peripheral Vascular Disease Symposium II: screening for atherosclerotic vascular diseases: should nationwide programs be instituted?
|
Circulation
|
2008
|
0.95
|
|
52
|
Risk factor profile and management of cerebrovascular patients in the REACH Registry.
|
Cerebrovasc Dis
|
2008
|
0.95
|
|
53
|
2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery.
|
Catheter Cardiovasc Interv
|
2011
|
0.94
|
|
54
|
2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS Key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to develop Clinical Data Standards for peripheral atherosclerotic vascular disease).
|
J Am Coll Cardiol
|
2011
|
0.93
|
|
55
|
Carotid intima-media thickness testing by non-sonographer clinicians: the office practice assessment of carotid atherosclerosis study.
|
J Am Soc Echocardiogr
|
2007
|
0.92
|
|
56
|
Atherosclerotic Vascular Disease Conference: Writing Group V: medical decision making and therapy.
|
Circulation
|
2004
|
0.92
|
|
57
|
International heterogeneity in diagnostic frequency and clinical outcomes of ascending aortic intramural hematoma.
|
J Am Soc Echocardiogr
|
2007
|
0.91
|
|
58
|
Association of anger proneness, depression and low social support with peripheral arterial disease: the Atherosclerosis Risk in Communities Study.
|
Vasc Med
|
2005
|
0.91
|
|
59
|
Ultrasound detection of increased carotid intima-media thickness and carotid plaque in an office practice setting: does it affect physician behavior or patient motivation?
|
J Am Soc Echocardiogr
|
2008
|
0.90
|
|
60
|
Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease.
|
Vasc Med
|
2010
|
0.89
|
|
61
|
2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease).
|
Circulation
|
2011
|
0.89
|
|
62
|
Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004.
|
Atherosclerosis
|
2008
|
0.89
|
|
63
|
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease).
|
Circulation
|
2010
|
0.89
|
|
64
|
Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US outpatients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) registry.
|
Am Heart J
|
2009
|
0.88
|
|
65
|
Postgraduate training in vascular medicine: proposed requirements and standards.
|
Vasc Med
|
2003
|
0.87
|
|
66
|
Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease.
|
Vasc Med
|
2004
|
0.87
|
|
67
|
Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort.
|
Vasc Med
|
2007
|
0.87
|
|
68
|
Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes.
|
Atherosclerosis
|
2012
|
0.87
|
|
69
|
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease).
|
J Am Coll Cardiol
|
2010
|
0.87
|
|
70
|
Confirmation of reported aspirin use in community studies: utility of serum thromboxane B2 measurement.
|
Clin Appl Thromb Hemost
|
2013
|
0.86
|
|
71
|
Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication.
|
J Vasc Interv Radiol
|
2013
|
0.86
|
|
72
|
Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial.
|
Am Heart J
|
2003
|
0.86
|
|
73
|
Risk factors and outcomes for patients with vascular disease and serious bleeding events.
|
Heart
|
2011
|
0.84
|
|
74
|
Critical limb ischemia and stem cell research: anchoring hope with informed adverse event reporting.
|
Circulation
|
2006
|
0.84
|
|
75
|
The role of nutrition and body composition in peripheral arterial disease.
|
Nat Rev Cardiol
|
2012
|
0.84
|
|
76
|
The continuum of risk: vascular pathophysiology, function, and structure.
|
Circulation
|
2004
|
0.84
|
|
77
|
Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry.
|
Crit Pathw Cardiol
|
2009
|
0.84
|
|
78
|
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease).
|
Vasc Med
|
2010
|
0.84
|
|
79
|
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease). Developed in collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation; the American Diabetes Association; the Society for Atherosclerosis Imaging and Prevention; the Society for Cardiovascular Magnetic Resonance; the Society of Cardiovascular Computed Tomography; and the PAD Coalition. Endorsed by the American Academy of Podiatric Practice Management.
|
J Vasc Surg
|
2010
|
0.84
|
|
80
|
Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance.
|
Circulation
|
2012
|
0.83
|
|
81
|
Process of care and outcomes in patients with peripheral arterial disease.
|
J Gen Intern Med
|
2007
|
0.83
|
|
82
|
Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
|
Circulation
|
2010
|
0.82
|
|
83
|
Usefulness of increased skin cholesterol to identify individuals at increased cardiovascular risk (from the Predictor of Advanced Subclinical Atherosclerosis study).
|
Am J Cardiol
|
2008
|
0.81
|
|
84
|
Concomitant peripheral arterial disease and coronary artery disease: therapeutic opportunities.
|
Circulation
|
2004
|
0.81
|
|
85
|
An evidence-based score to detect prevalent peripheral artery disease (PAD).
|
Vasc Med
|
2012
|
0.80
|
|
86
|
Practice variation among cardiovascular physicians in management of patients with mitral regurgitation.
|
Am J Cardiol
|
2008
|
0.79
|
|
87
|
Carotid plaque and intima-media thickness and the incidence of ischemic events in patients with atherosclerotic vascular disease.
|
Vasc Med
|
2011
|
0.79
|
|
88
|
Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registry.
|
Stroke
|
2006
|
0.78
|
|
89
|
Peripheral arterial disease: medical care and prevention of complications.
|
Prev Cardiol
|
2002
|
0.78
|
|
90
|
Effective vascular therapeutics for critical limb ischemia: a role for registry-based clinical investigation.
|
Circ Cardiovasc Interv
|
2013
|
0.78
|
|
91
|
Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy.
|
Vasc Med
|
2004
|
0.78
|
|
92
|
Development of a multicenter peripheral arterial interventional database: the PVD-QI2.
|
Am Heart J
|
2005
|
0.77
|
|
93
|
"POBA Plus": will the balloon regain its luster?
|
Circulation
|
2008
|
0.77
|
|
94
|
ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease).
|
J Vasc Nurs
|
2011
|
0.77
|
|
95
|
The efficacy and safety of enhanced external counterpulsation in patients with peripheral arterial disease.
|
Vasc Med
|
2009
|
0.76
|
|
96
|
Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia.
|
J Vasc Interv Radiol
|
2013
|
0.76
|
|
97
|
The role of preoperative coronary angiography in the setting of type A acute aortic dissection: insights from the International Registry of Acute Aortic Dissection.
|
Am Heart J
|
2011
|
0.76
|
|
98
|
Developing pharmaceutical treatments for peripheral artery disease.
|
Expert Opin Investig Drugs
|
2003
|
0.75
|
|
99
|
Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosis.
|
Crit Pathw Cardiol
|
2010
|
0.75
|